HOME >> MEDICINE >> NEWS
Lilly studies try to shed light on impact of race

CHICAGO, June 1, 2007 -- Statistics show lung cancer is the leading cause of cancer death in African-Americans, with 21,550 new cases expected to be diagnosed and 16,700 deaths expected this year. Equally devastating, lung cancer is the leading cause of cancer death in Hispanic men and the second leading cause of cancer death in Hispanic women. Researchers at Eli Lilly and Company are actively investigating the efficacy and safety of lung cancer treatments ALIMTA (pemetrexed for injection) and GEMZAR (gemcitabine HCl for injection) in treating non-small cell lung cancer (NSCLC) in African-Americans, Hispanics and other diverse populations.

Two retrospective Lilly studies were unveiled today at the 43rd Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago, Ill. They offered cursory insight into how a diverse group of patients respond to treatment with Lilly chemotherapeutic options. One study analyzed data of chemonave African-American patients with stage IIIB/IV NSCLC treated with GEMZAR in combination with carboplatin or paclitaxel (Taxol) versus patients taking carboplatin in combination with paclitaxel. The second study provided data from six previous trials for non-Caucasian patients with advanced or metastatic NSCLC treated with ALIMTA.

African-Americans are often underrepresented in clinical trials and, therefore, little is known about the possible impact of race on the utility of many medications, said Coleman Obasaju, M.D., Ph.D., United States oncology medical director of Lilly and the principal investigator of these two studies. Because lung cancer is a particularly devastating disease, and a growing concern in the African-American population, it was a logical starting point for our analysis.

The GEMZAR study released at ASCO analyzed overall survival data from a previous randomized Phase III trial in the treatment of NSCLC, viewing data outcomes and toxicity data of 128 African-Americans compa
'"/>

Contact: Neil Hochman
n.hochman@cprworldwideusa.com
212-453-2067
CPR Worldwide
1-Jun-2007


Page: 1 2 3

Related medicine news :

1. Making science personal: Lilly Oncology to unveil 76 studies at ASCO 2007
2. Lilly Foundation gift to Indiana University Cancer Center
3. Acrux granted first grant in Europe, triggering payment from Lilly
4. International studies show high efficacy for HPV vaccine
5. Innovative device to treat brain cancer shows promise in early studies
6. Limiting eligibility for medical studies can omit women and African-Americans
7. Epidemiology of TB: Updates from CDC studies to be presented at ATS 2007
8. DOE commits $27.5M for uranium contaminant transport field studies
9. Clinical studies evaluate potential treatments for mouth ulcers
10. Call for greater use of comparative effectiveness studies to help advance disease management
11. Americans still not eating enough fruits and vegetables, according to 2 recent studies

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/31/2020)... ... August 31, 2020 , ... Colorado State ... high-quality, career-relevant, and affordable online education – is proud to announce its new ... the first of its kind in the nation, the 60-credit hour program is ...
(Date:8/31/2020)... ... ... pandemic and topsy-turvy economic outlook continues to put financial strain on many of us, so ... fat from our monthly expenses and put more into savings, if possible. , “That’s a ... financial safety net in place in case something were to happen to you,” says Lee ...
(Date:8/31/2020)... ... August 31, 2020 , ... In an effort to give back to ... 10 percent of each hotel room booked with a special new rate code to ... Indiana (RMHC-CNI) , effective immediately. Donations will be applied to any room type, ...
(Date:8/31/2020)... ... August 31, 2020 , ... ... outcomes for patients with advanced heart failure, today announced that the company has ... amount of $555,358 from the National Heart, Lung, and Blood Institute of the ...
(Date:8/28/2020)... ... August 28, 2020 , ... Ernst & Young LLP (EY ... Entrepreneur Of The Year® 2020 Florida Award finalist. Now in its 34th year, ... innovation, growth and prosperity as they build and sustain successful businesses that transform ...
Breaking Medicine News(10 mins):
(Date:9/3/2020)... ... September 03, 2020 , ... ... Vance Lab ( https://www.colorado.edu/lab/vance/masks ), an aerosol and engineering lab, conducted tests on ... protection against the COVID-19 virus than many other masks. Q&J face masks have ...
(Date:9/2/2020)... Texas (PRWEB) , ... September ... ... in the Fight Against Covid-19 , Advanced Penetration Technology, LLC, (APT) a ... solutions for patients utilizing non-prescription, Over The Counter (OTC) products, was today ...
(Date:9/1/2020)... DENVER (PRWEB) , ... September 01, 2020 , ... ... has been appointed to serve as Secretary to the Board of Trustees ... , Mile High United Way is a Denver-based nonprofit organization that fights ...
Breaking Medicine Technology:
Cached News: